Skip to main content

Advertisement

SpringerLink
Log in

Late effects and quality of life of childhood cancer survivors: Part 1. Impact of stem cell transplantation

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

To examine the late effects and health-related quality of life among childhood cancer survivors (CCS) after stem cell transplantation (SCT), we performed a cross-sectional survey using self-rating questionnaires. The subjects were divided into 3 groups: SCT-treated CCS, CCS treated without SCT, and the general population who matched for age, gender, residential area, and work status with the CCS. We analyzed the questionnaires of 185 CCS and 1,000 control participants. The median ages of CCS at diagnosis and survey were 8 and 22 years, respectively. The mean final heights of male and female participants were significantly lower for SCT-treated CCS than for CCS treated without SCT and the controls. Among the SCT-treated CCS, >40% were underweight (BMI < 18.5). Late effects were observed in 78% of SCT-treated CCS versus 45% of CCS treated without SCT. Multivariate analysis revealed that >15 years’ duration after therapy completion (OR 2.95; p = 0.014), solid tumors (4.31; p = 0.040), radiotherapy (2.82; p = 0.009), recurrence (4.22; p = 0.017), and SCT (3.39; p = 0.014) were significant risk factors for late effects. Subjective symptoms were significantly frequent in SCT-treated CCS. Physical dysfunction, psychological stress, and social adaptation problems were observed in >70% of SCT-treated CCS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Robison LL, Armstrong GT, Boice JD, Chow EJ, Davies SM, Donaldson SS, et al. The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research. J Clin Oncol. 2009;27(14):2308–18. doi:10.1200/JCO.2009.22.3339.

    Article  PubMed  Google Scholar 

  2. Hawkins MM, Lancashire ER, Winter DL, Frobisher C, Reulen RC, Taylor AJ, et al. The British Childhood Cancer Survivor Study: objectives, methods, population structure, response rates and initial descriptive information. Pediatr Blood Cancer. 2008;50(5):1018–25. doi:10.1002/pbc.21335.

    Article  CAS  PubMed  Google Scholar 

  3. Geenen MM, Cardous-Ubbink MC, Kremer LC, van den Bos C, van der Pal HJ, Heinen RC, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA. 2007;297(24):2705–15.

    Article  CAS  PubMed  Google Scholar 

  4. Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572–82. doi:10.1056/NEJMsa060185.

    Article  CAS  PubMed  Google Scholar 

  5. Mertens AC, Yasui Y. Methodological issues in the study of survivors of childhood cancer. In: Schwartz C, et al., editors. Survivors of childhood and adolescent cancer. Berlin: Springer; 2005. p. 321–32.

    Chapter  Google Scholar 

  6. Bunin N, DiDomenico C, DGuzikowski V. Hematopoietic stem cell transplantation. In: Schwartz C, et al., editors. Survivors of childhood and adolescent cancer. Berlin: Springer; 2005. p. 271–82.

    Chapter  Google Scholar 

  7. Skinner R, Leiper A. Bone marrow transplantation. In: Wallace H, Green D, editors. Late effects of childhood cancer. London: Arnold; 2004. p. 304–19.

    Google Scholar 

  8. Friedrichs B, Tichelli A, Bacigalupo A, Russell NH, Ruutu T, Shapira MY, et al. Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial. Lancet Oncol 2010; doi:10.1016/S1470-2045(09)70352-3.

  9. Lof CM, Winiarski J, Giesecke A, Ljungman P, Forinder U. Health-related quality of life in adult survivors after paediatric allo-SCT. Bone Marrow Transplant. 2009;43(6):461–8. doi:10.1038/bmt.2008.338.

    Article  CAS  PubMed  Google Scholar 

  10. Dixon-Woods M, Young B, Heney D, editors. Rethinking experiences of childhood cancer. 1st ed. New York: Open University Press; 2005. p. 77–93.

    Google Scholar 

  11. Brennan BM, Shalet SM. Endocrine late effects after bone marrow transplant. Br J Haematol. 2002;118(1):58–66.

    Article  PubMed  Google Scholar 

  12. Leiper AD. Non-endocrine late complications of bone marrow transplantation in childhood: part I. Br J Haematol. 2002;118(1):3–22.

    Article  PubMed  Google Scholar 

  13. Leiper AD. Non-endocrine late complications of bone marrow transplantation in childhood: part II. Br J Haematol. 2002;118(1):23–43.

    Article  PubMed  Google Scholar 

  14. Sanders JE. Chronic graft-versus-host disease and late effects after hematopoietic stem cell transplantation. Int J Hematol. 2002;76(Suppl 2):15–28.

    Article  PubMed  Google Scholar 

  15. Socie G, Salooja N, Cohen A, Rovelli A, Carreras E, Locasciulli A, et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood. 2003;101(9):3373–85.

    Article  CAS  PubMed  Google Scholar 

  16. Chemaitilly W, Boulad F, Sklar C. Endocrine complications of childhood hematopoietic stem–cell transplantation. In: Kline R, editor. Pediatric hematopoietic stem cell transplantation. New York: Informa Healthcare; 2006. p. 287–398.

    Google Scholar 

  17. Miyoshi Y, Ohta H, Hashii Y, Tokimasa S, Namba N, Mushiake S, et al. Endocrinological analysis of 122 Japanese childhood cancer survivors in a single hospital. Endocr J. 2008;55(6):1055–63.

    Article  PubMed  Google Scholar 

  18. Ishiguro H, Yasuda Y, Tomita Y, Shinagawa T, Shimizu T, Morimoto T, et al. Long-term follow-up of thyroid function in patients who received bone marrow transplantation during childhood and adolescence. J Clin Endocrinol Metab. 2004;89(12):5981–6.

    Article  CAS  PubMed  Google Scholar 

  19. Diller L, Chow EJ, Gurney JG, Hudson MM, Kadin-Lottick NS, Kawashima TI, et al. Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings. J Clin Oncol. 2009;27(14):2339–55. doi:10.1200/JCO.2008.21.1953.

    Article  PubMed  Google Scholar 

  20. Ishiguro H, Yasuda Y, Tomita Y, Shinagawa T, Shimizu T, Morimoto T, et al. Gonadal shielding to irradiation is effective in protecting testicular growth and function in long-term survivors of bone marrow transplantation during childhood or adolescence. Bone Marrow Transplant. 2007;39(8):483–90.

    Article  CAS  PubMed  Google Scholar 

  21. Sanders JE. Growth and development after hematopoietic cell transplant in children. Bone Marrow Transplant. 2008;41(2):223–7. doi:10.1038/sj.bmt.1705875.

    Article  CAS  PubMed  Google Scholar 

  22. Meacham LR, Gurney JG, Mertens AC, Ness KK, Sklar CA, Robison LL, et al. Body mass index in long-term adult survivors of childhood cancer: a report of the Childhood Cancer Survivor Study. Cancer. 2005;103(8):1730–9. doi:10.1002/cncr.20960.

    Article  PubMed  Google Scholar 

  23. Bresters D, van Gils IC, Kollen WJ, Ball LM, Oostdijk W, van der Bom JG, et al. High burden of late effects after haematopoietic stem cell transplantation in childhood: a single-centre study. Bone Marrow Transplant. 2010;45(1):79–85. doi:10.1038/bmt.2009.92.

    Article  CAS  PubMed  Google Scholar 

  24. Nandagopal R, Laverdiere C, Mulrooney D, Hudson MM, Meacham L. Endocrine late effects of childhood cancer therapy: a report from the Children’s Oncology Group. Horm Res. 2008;69(2):65–74. doi:10.1159/000111809.

    Article  CAS  PubMed  Google Scholar 

  25. van der Pas-van Voskuilen IG, Veerkamp JS, Raber-Durlacher JE, Bresters D, van Wijk AJ, Barasch A, et al. Long-term adverse effects of hematopoietic stem cell transplantation on dental development in children. Support Care Cancer. 2009;17(9):1169–75. doi:10.1007/s00520-008-0567-1.

    Article  PubMed  Google Scholar 

  26. Hudson MM, Mulrooney DA, Bowers DC, Sklar CA, Green DM, Donaldson SS, et al. High-risk populations identified in Childhood Cancer Survivor Study investigations: implications for risk-based surveillance. J Clin Oncol. 2009;27(14):2405–14. doi:10.1200/JCO.2008.21.1516.

    Article  PubMed  Google Scholar 

  27. Nuss SL, Wilson ME. Health-related quality of life following hematopoietic stem cell transplant during childhood. J Pediatr Oncol Nurs. 2007;24(2):106–15. doi:10.1177/1043454206296033.

    Article  PubMed  Google Scholar 

  28. Forinder U, Lof C, Winiarski J. Quality of life and health in children following allogeneic SCT. Bone Marrow Transplant. 2005;36(2):171–6.

    Article  CAS  PubMed  Google Scholar 

  29. Ishida Y, Honda M, Kamibeppu K, Ozono S, Iwai T, Kakee N, et al. Cross-sectional survey on the late effects and QOL of childhood cancer survivors. Part 1. J Jpn Pediatr Soc 2010;114(4):665–75 (Japanese).

    Google Scholar 

  30. Rizzo JD, Wingard JR, Tichelli A, Lee SJ, Van Lint MT, Burns LJ, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2006;12(2):138–51.

    Article  PubMed  Google Scholar 

  31. Satwani P, Morris E, Bradley MB, Bhatia M, van de Ven C, Cairo MS. Reduced intensity and non-myeloablative allogeneic stem cell transplantation in children and adolescents with malignant and non-malignant diseases. Pediatr Blood Cancer. 2008;50(1):1–8. doi:10.1002/pbc.21303.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The institutions that provided patient data and enabled recruitment of CCS in the survey are listed in Appendix 1. This study was supported by research grants from the Japanese Ministry of Health, Labor and Welfare (Grant No. 18-14: “Study of quality of life and prognosis in childhood cancer survivors and establishment of the long-term follow-up system”).

Conflict of interest statement

The authors declare no financial interests.

Author information

Author notes

  1. Yasushi Ishida

    Present address: Department of Pediatrics, St. Luke’s International Hospital, 10-1 Akashi-cho, Chuo-ku, Tokyo, 104-0044, Japan

Authors and Affiliations

  1. Department of Pediatrics, Ehime University Graduate School of Medicine, Toon, Japan

    Yasushi Ishida & Misato Honda

  2. Department of Pediatrics, Kurume University School of Medicine, Fukuoka, Japan

    Shuichi Ozono & Hiroko Inada

  3. Institute for Clinical Research, National Kyusyu Cancer Center, Fukuoka, Japan

    Jun Okamura

  4. Department of Pediatrics, Niigata Cancer Center Hospital, Niigata, Japan

    Keiko Asami

  5. Department of Pediatrics and Clinical Research Center, Nagoya Medical Center, Aichi, Japan

    Naoko Maeda & Keizo Horibe

  6. Department of Epidemiology, National Research Institute for Child Health and Development, Tokyo, Japan

    Naoko Sakamoto

  7. Department of Hemato-oncology, Kagawa Children’s Hospital, Kagawa, Japan

    Tsuyako Iwai

  8. Department of Family Nursing, The University of Tokyo, Tokyo, Japan

    Kiyoko Kamibeppu

  9. Department of Health Policy, National Research Institute for Child Health and Development, Tokyo, Japan

    Naoko Kakee

Authors
  1. Yasushi Ishida
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Misato Honda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shuichi Ozono
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jun Okamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Keiko Asami
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Naoko Maeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Naoko Sakamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hiroko Inada
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Tsuyako Iwai
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Kiyoko Kamibeppu
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Naoko Kakee
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Keizo Horibe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yasushi Ishida.

Appendices

Appendix 1

See Table 7.

Table 7  
Full size table

Appendix 2

Hearing impairment, tinnitus, vertigo, vision acuity, cataract, glaucoma, diplopia, dry eye, smell abnormality, urinary tract infection, urolithiasis, renal failure, urinary examination abnormality, hypothyroidism, hyperthyroidism, goiter, diabetes mellitus, growth hormone deficiency, growth hormone replacement, osteoporosis, delayed puberty, precocious puberty, suspected infertility, examination for infertility, menarche, irregular menstruation, pill usage, semen problems, any heart disease, arrhythmia, heart failure, angina, myocardial infarction, hypertension, stroke, valvular heart disease, thrombosis, heart failure during pregnancy, chronic bronchitis, bronchial asthma, recurrent tonsillitis, pulmonary emphysema, pulmonary fibrosis, other lung disease, gallstone, hepatitis, jaundice, liver cirrhosis, peptic ulcer, any intestinal disease, chronic diarrhea, chronic constipation, any tooth disease, scoliosis, any other spine disease, extremity dysfunction, limb length discrepancy, joints problems, cerebral palsy, paralysis, developmental delay, epilepsy, headache, faintness/tremor, muscle weakness, chronic pain, sensory disturbance, dysphagia, other neurological disorders, skin problems, alopecia, and any allergic disease.

About this article

Cite this article

Ishida, Y., Honda, M., Ozono, S. et al. Late effects and quality of life of childhood cancer survivors: Part 1. Impact of stem cell transplantation. Int J Hematol 91, 865–876 (2010). https://doi.org/10.1007/s12185-010-0584-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-010-0584-y

Keywords

Search

Navigation